Basic Information
PICOPREP Powder for Oral Solution
POWDER, FOR SOLUTION
Regulatory Information
SIN14303P
January 30, 2013
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 4, 2025
Company Information
FERRING PHARMACEUTICALS PRIVATE LIMITED
FERRING PHARMACEUTICALS PRIVATE LIMITED
Active Ingredients
Strength: 12 g
Strength: 3.5 g
Strength: 10 mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** - Hypersensitivity to the active substances or to any excipients of the product - Congestive cardiac failure - Gastric retention - Gastro-intestinal ulceration - Toxic colitis - Toxic megacolon - Ileus - Nausea and vomiting - Acute surgical abdominal conditions such as acute appendicitis - Known or suspected gastro-intestinal obstruction or perforation. - Severe dehydration - Rhabdomyolysis - Hypermagnesemia - Active inflammatory bowel disease - In patients with severely reduced renal function, accumulation of magnesium in plasma may occur. Another preparation should be used in such cases.
Indication Information
**THERAPEUTIC INDICATIONS** To clean the bowel prior to X-ray examination or endoscopy. To clean the bowel prior to surgery when judged clinically necessary (see section Special Warnings and Precautions for Use regarding open colorectal surgery – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).